EUCODIS Bioscience delivers high-performance enzyme solutions for highly specific applications in biopharma, fine chemicals, cosmetics industry and others.
With a portfolio of over 50 enzymes including innovative lipases, beta-lactamases, peroxidases and other enzymes EUCODIS Bioscience has a proven track record of providing customized enzyme solutions.
EUCODIS Bioscience provides customized services in recombinant protein and enzyme production by covering the whole spectrum of bioprocess development up to industrial-scale manufacture of your target proteins under ISO9001.
Within the ChitoTex project EUCODIS Bioscience, the Fraunhofer IGB and Norwegian University of Life Sciences (NMBU) collaborated to establish a new enzyme based approach to produce chitosan for the treatment of textile fibers and yarns in a more sustainable way. EUCODIS played an important role in the screening and modification of those enzymes aiming to develop suitable expression systems as well as efficient, stable, recombinant enzymes to produce chitosan.
EUCODIS Bioscience, an Austrian biotechnology company with strong expertise in industrial enzyme development, announces the completion of a development project for PrEP Biopharm Limited. In this collaboration, EUCODIS Bioscience developed an enzymatic method for production of a drug intermediate of PrEP-001, an immunomodulator for the prevention of the common cold and influenza and supplied key consumables for the GMP manufacturing process.
- Eucodis starts commercialization of tubulysin A and B
- ProBioGen AG and EUCODIS Bioscience sign agreement to commercialize C-LiNK, A novel antibody drug conjugation technology
- Antibody Drug Conjugate Using CTAT Linker Technology Shows Superior Efficacy in Xenograft Trial
- EUCODIS Bioscience participates in European ERA-IB project ChitoTex